Gastrointestinal polyps in children: Advances in molecular genetics, diagnosis, and management

Journal of Pediatrics

Volumn 138, Issue 5, 2001, Pages 621-628

  Corredor, Julissa ^a,b   Wambach, Jennifer ^a,b   Barnard, John ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADENOMATOUS POLYP; BANNAYAN RILEY RUVALCABA SYNDROME; CANCER RISK; CLINICAL FEATURE; COLONOSCOPY; COWDEN SYNDROME; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; GASTROINTESTINAL POLYPOSIS; HUMAN; INCIDENCE; JUVENILE POLYP; MOLECULAR GENETICS; ONCOGENE; PEUTZ JEGHERS SYNDROME; PREVALENCE; PRIORITY JOURNAL; PROCTOCOLECTOMY; RECTUM HEMORRHAGE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0035002479     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2001.113619     Document Type: Article

References (63)

1. Lessons from hereditary colorectal cancer
2. Polyps of the rectum and colon in children
3. Polyps and polyposis syndromes
4. Juvenile polyps of the colon and rectum
5. The changing pattern of juvenile polyps
6. Colocolic intussusception in a three-year-old child caused by a colonic polyp
7. Diagnosis and management of colonic polyps in children
8. Symptomatic colonic polyps in childhood: Not so benign
9. Genetic alterations and epithelial dysplasla in juvenile polyposis syndrome and sporadic juvenile polyps
10. Ornithine decarboxylase and tyrosine kinase activity in juvenile polyps of childhood
11. Hereditary gastrointestinal polyposis and nonpolyposis syndromes
12. Familial adenomatous polyposis in a 5 year old child: A clinical pathological and a molecular genetic study
13. The risk of upper gastrointestinal cancer in familial adenomatous polyposis
14. Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome
15. Retinal pigment epithelium lesions as a biomarker of disease in patients with familial adenomatous polyposis
16. Care of patients and their families with familial adenomatous polyposis
17. Phenotype and cancer risk of various polyposis syndromes
18. Identification and characterization of the familial adenomatous polyposis coli gene
19. Familial adenomatous polyposis: From bedside to benchside
20. The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis
21. Phenotypic expression of disease in families that have mutations in the 5′ region of the adenomatous polyposis coil gene
22. Regionally clustered APC mutations are associated with a severe phenotype and occur at a high frequency in new mutation cases of adenomatous polyposis coli
23. Molecular diagnosis of familial aclenomatous polyposis
24. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis
25. Genetic testing and surgical decision making in hereditary colorectal cancer
26. Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis
27. Negative genetic test result in familial adenomatous polyposis: Clinical screening implications
28. Testing children for cancer genes: The rule of earliest onset
29. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
30. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
31. The clinical potential of cyclooxygenase-2-specific inhibitors
32. Peutz-Jeghers syndrome: 78-year follow-up of the original family
33. Peutz-Jeghers syndrome
34. Peutz-Jeghers syndrome in a neonate
35. Increased risk of cancer in Peutz-Jeghers syndrome
36. Colon cancer screening
37. Germline mutations of the LKB1 (STK11) gene in Peutz-Jeghers patients
38. Genetic heterogeneity in Peutz-Jeghers syndrome
39. Growth suppression by Lkbl is mediated by a G1 cell cycle arrest
40. Cowden syndrome
41. Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome
42. Molecular classification of the inherited hamartoma polyposis syndromes: Clearing the muddied waters
43. Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome
44. Germline PTEN mutations in Cowden syndrome-like families
45. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
46. Phenotyplc findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN
47. Management of infantile polyposis syndrome
48. Familial juvenile polyposis of the stomach
49. A survey ofphenotypic features in juvenile polyposis
50. Juvenile polyposis
51. Juvenile polyposis: A precancerous condition
52. Colorectal neoplasia in juvenile polyposis or juvenile polyps
53. The risk of gastrointestinal carcinoma in familial juvenile polyposis
54. Mutations in the SMAD4/DPCA gene in juvenile polyposis
55. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis
56. Frequent 4-bp deletion in exon 9 of the SMAD4/MADH4 gene in familial juvenile polyposis patients
57. Signal transduction by transforming growth factor β: A cooperative paradigm with extensive negative regulation
58. Screening SMAD1, SMAD2, SMAD3 and SMAD5 for germline mutations in juvenile polyposis syndrome
59. A juvenile polyposis tumor suppressor locus at 10q22 is deleted from nonepithelial cells in the lamina propria
60. PTEN germ-line mutations in juvenile polyposis coli
61. Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome
62. Solitary juvenile polyps: Not a marker for subsequent malignancy
63. Colonic polyps: Experience in 236 Indian children